CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
Abstract Background Delirium and dementia share symptoms of cognitive dysfunctions, and mechanisms of neuroinflammation appear involved in both conditions. Triggering receptor expressed on myeloid cells 2 (TREM2) is linked to dementia and neurodegenerative disease. It encodes expression of an innate...
Main Authors: | Kristi Henjum, Else Quist-Paulsen, Henrik Zetterberg, Kaj Blennow, Lars N. G. Nilsson, Leiv Otto Watne |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-11-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12974-018-1331-1 |
Similar Items
-
Plasma tau complements CSF tau and P‐tau in the diagnosis of Alzheimer's disease
by: Silvia Fossati, et al.
Published: (2019-12-01) -
Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease
by: Yanaika S. Hok-A-Hin, et al.
Published: (2023-05-01) -
Dynamic changes of CSF sTREM2 in preclinical Alzheimer’s disease: the CABLE study
by: Ling-Zhi Ma, et al.
Published: (2020-04-01) -
CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline
by: Marc Suárez‐Calvet, et al.
Published: (2018-12-01) -
CSF sTREM2 in neurological diseases: a two-sample Mendelian randomization study
by: Ming-Hao Dong, et al.
Published: (2022-04-01)